Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China

BACKGROUND: Plasmodium vivax is the main malaria parasite in China, and China is now making efforts to eliminate malaria by 2020. Radical cure of vivax malaria is one of challenges for malaria elimination. The purpose is to evaluate the efficacy and safety of artemisinin-naphthoquine (ANQ) versus ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Yang, Heng-lin, Xu, Jian-Wei, Wang, Jia-zhi, Nie, Ren-hua, Li, Chun-fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833846/
https://www.ncbi.nlm.nih.gov/pubmed/24215565
http://dx.doi.org/10.1186/1475-2875-12-409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833846/
https://www.ncbi.nlm.nih.gov/pubmed/24215565
http://dx.doi.org/10.1186/1475-2875-12-409

Ejemplares similares